Postgraduate Course

Personalized CRC Screening and Surveillance in the Average-Risk Patient

Sunday, October 7
10:20 AM - 10:40 AM
Location: Terrace Ballroom (level 400)

Category: Colorectal Cancer Prevention

Learning Objectives:

Douglas J. Robertson

Professor of Medicine, Geisel School of Medicine at Dartmouth & the Dartmouth Institute, Hanover, NH; Chief, Gastroenterology
White River Junction VAMC
White River Junction, Vermont

Dr. Robertson is Chief of Gastroenterology at the White River Junction VA (White River Junction, VT) and Professor of Medicine at the Geisel School of Medicine at Dartmouth and the Dartmouth Institute in Hanover, NH. He completed his GI fellowship training program at the University of North Carolina at Chapel Hill. During GI fellowship, he also attended the UNC School of Public Health and earned an MPH in Epidemiology. Prior to GI training, he completed his Medical School, Internal Medicine Residency and Chief Medical Residency all at the University of Connecticut in Farmington, CT. Dr. Robertson's research interests are both in the epidemiology of colorectal cancer and the utility of screening and surveillance for this disease. He previously served as the Clinical Director of the Polyp Prevention Study Group (PPSG) that has performed large trials examining aspirin, folate, calcium and Vitamin D on the prevention of polyps. In addition, he has used large data sets associated with the PPSG trials and the Danish National Registry to understand the associations of factors like drugs and diet on the development of colorectal neoplasia. Currently he is the National Co-Chair of VA Cooperative Study #577 CONFIRM trial ( Identifier: NCT01239082). This 14 year VA-funded, randomized, prospective trial will compare colonoscopy to annual stool testing with FIT in 50,000 average risk Veterans. This study is the first large-scale, prospective trial of colonoscopy in the United States using colorectal cancer mortality as the main outcome. Dr. Robertson currently serves as a Special Section Editor for Gastroenterology and is a member of the Editorial Board for Clinical Gastroenterology and Hepatology. He has previously served as an ACG Research Committee and is currently on the Practice Parameters Committee. He also is a member of the U.S. Multi-society Task Force on colorectal cancer.


Send Email for Douglas Robertson


Personalized CRC Screening and Surveillance in the Average-Risk Patient

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Personalized CRC Screening and Surveillance in the Average-Risk Patient